| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |